These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 7802648)
1. Steroid hormone modulation of vitamin D receptor levels in human MG-63 osteosarcoma cells. Mahonen A; Mäenpää PH Biochem Biophys Res Commun; 1994 Dec; 205(2):1179-86. PubMed ID: 7802648 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells. Godschalk M; Levy JR; Downs RW J Bone Miner Res; 1992 Jan; 7(1):21-7. PubMed ID: 1312760 [TBL] [Abstract][Full Text] [Related]
3. Type I procollagen synthesis is regulated by steroids and related hormones in human osteosarcoma cells. Mahonen A; Jukkola A; Risteli L; Risteli J; Mäenpää PH J Cell Biochem; 1998 Feb; 68(2):151-63. PubMed ID: 9443071 [TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo. Reinhardt TA; Horst RL Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926 [TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428 [TBL] [Abstract][Full Text] [Related]
6. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697 [TBL] [Abstract][Full Text] [Related]
7. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S; Krishnan AV; Feldman D Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825 [TBL] [Abstract][Full Text] [Related]
8. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells. Guerrero R; de la Piedra C; Teixeiro E; Bragado R; Traba ML J Rheumatol; 2004 Jan; 31(1):167-72. PubMed ID: 14705237 [TBL] [Abstract][Full Text] [Related]
9. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor gene expression is up-regulated by 1, 25-dihydroxyvitamin D3 in 3T3-L1 preadipocytes. Kamei Y; Kawada T; Kazuki R; Ono T; Kato S; Sugimoto E Biochem Biophys Res Commun; 1993 Jun; 193(3):948-55. PubMed ID: 7686756 [TBL] [Abstract][Full Text] [Related]
11. Dexamethasone increases the expression of retinoid X receptor genes in rat hepatoma cell lines. Wan YJ; Wang L; Wu TC Lab Invest; 1994 Apr; 70(4):547-52. PubMed ID: 8176893 [TBL] [Abstract][Full Text] [Related]
12. Modulation of TNF-alpha expression in bone marrow macrophages: involvement of vitamin D response element. Hakim I; Bar-Shavit Z J Cell Biochem; 2003 Apr; 88(5):986-98. PubMed ID: 12616536 [TBL] [Abstract][Full Text] [Related]
13. Effects of retinoic acid and dexamethasone on proliferation, differentiation, and glucocorticoid receptor expression in cultured human osteosarcoma cells. Song LN Oncol Res; 1994; 6(3):111-8. PubMed ID: 7994082 [TBL] [Abstract][Full Text] [Related]
14. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells. Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Kong J; Li YC Am J Physiol Endocrinol Metab; 2006 May; 290(5):E916-24. PubMed ID: 16368784 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D and the hematolymphopoietic tissue: a 1994 update. Manolagas SC; Yu XP; Girasole G; Bellido T Semin Nephrol; 1994 Mar; 14(2):129-43. PubMed ID: 8177980 [TBL] [Abstract][Full Text] [Related]
17. Role of vitamin D3 receptor in the synergistic differentiation of WEHI-3B leukemia cells by vitamin D3 and retinoic acid. Li J; Finch RA; Sartorelli AC Exp Cell Res; 1999 Jun; 249(2):279-90. PubMed ID: 10366427 [TBL] [Abstract][Full Text] [Related]
18. Homologous and heterologous regulation of 1,25-dihydroxyvitamin D-3 receptor mRNA levels in human osteosarcoma cells. Mahonen A; Pirskanen A; Mäenpää PH Biochim Biophys Acta; 1991 Jan; 1088(1):111-8. PubMed ID: 1846564 [TBL] [Abstract][Full Text] [Related]
19. Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3. Arbour NC; Prahl JM; DeLuca HF Mol Endocrinol; 1993 Oct; 7(10):1307-12. PubMed ID: 8264662 [TBL] [Abstract][Full Text] [Related]
20. Effects of retinoic acid on steroid and vitamin D3 receptors in cultured mouse osteosarcoma cells. Suzuki S; Koga M; Takaoka K; Ono K; Sato B Bone; 1993; 14(1):7-12. PubMed ID: 8382933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]